Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study

Details 詳細情報について

• CRID

  1360298762034032256

• DOI

  10.1016/j.intimp.2021.107755

• ISSN

  15675769

• Web Site

  https://api.elsevier.com/content/article/PII:S156757692100391X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S156757692100391X?httpAccept=text/plain

• Data Source

  • Crossref